---
pmid: '37943617'
title: Biallelic Cys141Tyr variant of SEL1L is associated with neurodevelopmental
  disorders, agammaglobulinemia, and premature death.
authors:
- Weis D
- Lin LL
- Wang HH
- Li ZJ
- Kusikova K
- Ciznar P
- Wolf HM
- Leiss-Piller A
- Wang Z
- Wei X
- Weis S
- Skalicka K
- Hrckova G
- Danisovic L
- Soltysova A
- Yang TT
- Feichtinger RG
- Mayr JA
- Qi L
journal: J Clin Invest
year: '2024'
full_text_available: false
pmcid: PMC10786703
doi: 10.1172/JCI170882
---

# Biallelic Cys141Tyr variant of SEL1L is associated with neurodevelopmental disorders, agammaglobulinemia, and premature death.
**Authors:** Weis D, Lin LL, Wang HH, Li ZJ, Kusikova K, Ciznar P, Wolf HM, Leiss-Piller A, Wang Z, Wei X, Weis S, Skalicka K, Hrckova G, Danisovic L, Soltysova A, Yang TT, Feichtinger RG, Mayr JA, Qi L
**Journal:** J Clin Invest (2024)
**DOI:** [10.1172/JCI170882](https://doi.org/10.1172/JCI170882)
**PMC:** [PMC10786703](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10786703/)

## Abstract

1. J Clin Invest. 2024 Jan 16;134(2):e170882. doi: 10.1172/JCI170882.

Biallelic Cys141Tyr variant of SEL1L is associated with neurodevelopmental 
disorders, agammaglobulinemia, and premature death.

Weis D(1)(2), Lin LL(3)(4), Wang HH(3)(4), Li ZJ(3)(5), Kusikova K(6), Ciznar 
P(2), Wolf HM(7)(8), Leiss-Piller A(7), Wang Z(3)(4), Wei X(3)(4), Weis S(9), 
Skalicka K(2), Hrckova G(2), Danisovic L(10), Soltysova A(11)(12), Yang TT(4), 
Feichtinger RG(13), Mayr JA(13), Qi L(3)(4)(5).

Author information:
(1)Department of Medical Genetics, Kepler University Hospital, School of 
Medicine, Johannes Kepler University, Linz, Austria.
(2)Department of Pediatrics, Faculty of Medicine, Comenius University Bratislava 
and National Institute of Children's Diseases, Bratislava, Slovakia.
(3)Department of Molecular Physiology and Biological Physics, University of 
Virginia, Charlottesville, Virginia, USA.
(4)Department of Molecular & Integrative Physiology and.
(5)Department of Biological Chemistry, University of Michigan Medical School, 
Ann Arbor, Michigan, USA.
(6)Department of Pediatric Neurology, Faculty of Medicine, Comenius University 
Bratislava and National Institute of Children's Diseases, Bratislava, Slovakia.
(7)Immunology Outpatient Clinic, Vienna, Austria.
(8)Sigmund Freud Private University-Medical School, Vienna, Austria.
(9)Division of Neuropathology, Neuromed Campus, Department of Pathology and 
Molecular Pathology, Kepler University Hospital, Johannes Kepler University, 
Linz, Austria.
(10)Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of 
Medicine, and.
(11)Faculty of Natural Sciences, Department of Molecular Biology, Comenius 
University, Bratislava, Slovakia.
(12)Institute for Clinical and Translational Research, Biomedical Research 
Centre, Slovak Academy of Sciences, Bratislava, Slovakia.
(13)University Children's Hospital, Salzburger Landeskliniken 
Universit√§tsklinikum (SALK) and Paracelsus Medical University (PMU), Salzburg, 
Austria.

Comment in
    Hypomorphic human SEL1L and HRD1 variants uncouple multilayered 
ER-associated degradation machinery.

Suppressor of lin-12-like-HMG-CoA reductase degradation 1 (SEL1L-HRD1) 
ER-associated degradation (ERAD) plays a critical role in many physiological 
processes in mice, including immunity, water homeostasis, and energy metabolism; 
however, its relevance and importance in humans remain unclear, as no disease 
variant has been identified. Here, we report a biallelic SEL1L variant (p. 
Cys141Tyr) in 5 patients from a consanguineous Slovakian family. These patients 
presented with not only ERAD-associated neurodevelopmental disorders with onset 
in infancy (ENDI) syndromes, but infantile-onset agammaglobulinemia with no 
mature B cells, resulting in frequent infections and early death. This variant 
disrupted the formation of a disulfide bond in the luminal fibronectin II domain 
of SEL1L, largely abolishing the function of the SEL1L-HRD1 ERAD complex in part 
via proteasomal-mediated self destruction by HRD1. This study reports a disease 
entity termed ENDI-agammaglobulinemia (ENDI-A) syndrome and establishes an 
inverse correlation between SEL1L-HRD1 ERAD functionality and disease severity 
in humans.

DOI: 10.1172/JCI170882
PMCID: PMC10786703
PMID: 37943617 [Indexed for MEDLINE]
